Edema recorrente associado à co-formulação de lopinavir e ritonavir
AUTOR(ES)
Pinto, Jorge Francisco C., Eyer-Silva, Walter A., Morais-de-Sá, Carlos Alberto
FONTE
Revista da Sociedade Brasileira de Medicina Tropical
DATA DE PUBLICAÇÃO
2004-08
RESUMO
Documentos Relacionados
- Uso de lopinavir/ritonavir associado com ergotamina resultando em amputação de pé: comunicação breve
- Pharmacokinetics of Adjusted-Dose Lopinavir-Ritonavir Combined with Rifampin in Healthy Volunteers
- Lopinavir/ritonavir dosing during pregnancy in Brazil and maternal/infant laboratory abnormalities
- Dyslipidaemia associated with the highly active antiretroviral therapy in aids patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir)
- Estimation of Serum-Free 50-Percent Inhibitory Concentrations for Human Immunodeficiency Virus Protease Inhibitors Lopinavir and Ritonavir